Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: juneau_boy who wrote (466)	10/10/2000 8:07:50 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3559

<<Aren't the next results on the Axokine trial still expected around December (if I remember right?)>> Didn't you hear for: "buy on rumor, sell on news"! Someone, somewhere has to start rumor. <g> <<OT, not to beat a dead horse, but there is continued action in the ISIP arena...2302 is back, patents getting licensed..is it time to look at this one again do you think?>. Isis-2302...too little, too late. Sector has many good bios and ISIP may just be lost of time and good opportunity. I do not follow ISIP with great interest. Miljenko